Consulting
Industries
Research Tools
Clinical Diagnostics
Pharma & Biotech
Financial Services
Featured Client Results
Pharma & Biotech
Biopharma Genomic Testing Market Research
Clinical Diagnostics
Minimal Residual Disease (MRD) Application Prioritization and Evidence Generation Strategy
Research Tools
Methylation Analysis Opportunity Identification for Ultra-Sensitive Detection Platform
View All Client Results
Data & Platforms
Market Reports
Spatial Biology Market Report - First Edition: 2022
Clinical Spatial Biology + Digital Pathology Competitive Intelligence Report - H1 2022
Global Oncology Liquid Biopsy Market
View All Reports
Proprietary Databases
DxBooks
TheraTrack
Ad Boards
MRD Ad Board
View All Campaigns
Search All Transcripts
Platforms
BioTrack
Dexter Expert Network
View All Data & Platforms
Insights
About
Our Mission
Our Culture
Meet the Team
Impact Lab
Locations
CAreers
Why DeciBio?
Open Positions
Interviewing
FAQ
Contact
Infographic
DeciBio’s Insights From #JPM23
January 16, 2023
Authors
Stephane Budel
Founding Partner
Miguel Edwards
Partner
Andrew Aijian
Partner
Carl Schoellhammer
Principal
Steve Beuchaw
Partner
Katie Gillette
Senior Project Leader
Tina Wang
Project Leader
DeciBio Strategy Consulting
Want to hear more from our experts? Schedule an intro call today.
CONTACT US
Related Insights
Financial Services
DeciBio Ventures invests in $55m Replay seed funding round led by KKR & Co and OMX Ventures
Check out our latest feature on PE insider about recent news regarding DeciBio Ventures.
August 1, 2022
Financial Services
DeciBio Ventures Invests in Replay’s $55M seed funding round led by KKR & Co. and OMX Ventures
DeciBio Ventures invested in the seed funding round for Replay. KKR & Co. Inc. and OMX Ventures led this funding round, which totaled $55 million.
July 25, 2022
Financial Services
DeciBio Consulting adds Miguel Edwards, Ph.D., as a Partner and Head of its Bay Area Office
DeciBio Consulting, LLC, has tapped Miguel Edwards, Ph.D., as Partner.
January 10, 2022
Financial Services
DeciBio Consulting Announces Debut Venture Fund, DeciBio Ventures, to Support Ground-Breaking Precision Medicine Companies
DeciBio Ventures aims to invest in start-ups across both tools and therapeutics
December 15, 2021
View All Insights
Precision Medicine is evolving at a rapid pace
Discover how we can help
Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.